Abstract
Hemicrania continua is an uncommon headache disorder that requires complete response to indomethacin for its diagnosis, that becomes on most of the cases chronic pain resilient to treatment. On the other hand, temporomandibular pain is very common on the general population and happens to be undiagnosed most of the time when headache or migraines are happening at the same time. In this case we aim to highlight the importance of treating all concomitant diagnosis for a better long-term prognosis. In this paper, a case of a 51-year-old male with chronic resilient facial pain is presented. The patient described right sided facial pain with six years of evolution that started with no triggers. The pain was described as constant bilateral pressure being worse on the right side, located on the temples, masseteric and preauricular areas; with an intensity of 6 on a scale of 0 to 10. It is accompanied by episodes of paroxysmal pulsating hemifacial pain with autonomic symptoms (rhinorrhea, conjunctival injections and lacrimation). The pain during exacerbations was located on the right periorbital and hemifacial area and with an intensity of 10 on a scale of 0 to 10, lasting a few minutes to more than 2 hours. After the clinical examination and pain history, the patient was given the diagnosis of hemicrania continua and masticatory myofascial pain. He was started on Indomethacin 25mg twice a day and started on temporomandibular therapy (self-care, jaw exercises, motivation and advice for stress management). Three months after the first evaluation the patient reported total resolution of his symptoms. The main goal of this article is to highlight that the presence of temporomandibular disorders is common in patients with headaches, for which it is necessary to carry out a comprehensive approach for both entities, which include the therapies for treating axis I diagnosis and behavioral management for axis II, this including most of the time a multidisciplinary human centered approach.
References
Benoliel R., Eliav E. Primary Headache Disorders. Dent Clin North Am [Internet]. 2013; 57 (3): 513-39. Available from: http://dx.doi.org/10.1016/j.cden.2013.04.005
Olesen J. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018; 38 (1): 1-211.
Ramusino M., Perini G., Antonaci F., Costa A. The Treatment of Trigeminal Autonomic Cephalalgias: An Overview. J Oral Facial Pain Headache. 2019; 33 (1): 89-104.
Goadsby P.J., Cittadini E., Burns B., Cohen A.S. Trigeminal autonomic cephalalgias: Diagnostic and therapeutic developments. Curr Opin Neurol. 2008; 21 (3): 323-30.
Trucco M., Mainardi F., Maggioni F., Badino R., Zanchin G. Chronic paroxysmal hemicrania, hemicrania continua and SUNCT syndrome in association with other pathologies: A review. Cephalalgia. 2004; 24 (3): 173-84.
Hryvenko I., Cervantes-Chavarría A.R., Law A.S., Nixdorf D.R. Hemicrania continua: Case series presenting in an orofacial pain clinic. Cephalalgia. 2018; 38 (13): 1950-9.
Cittadini E., Goadsby P.J. Update on hemicrania continua. Curr Pain Headache Rep. 2011; 15 (1): 51-6.
Prakash S., Patel P. Hemicrania continua: Clinical review, diagnosis and management. J Pain Res. 2017; 10: 1493-509.
Pareja J.A., Álvarez M. The Usual Treatment of Trigeminal Autonomic Cephalalgias. 2013; 53 (9): 1401-1414.
Prevalence @ Www.Nidcr.Nih.Gov [Internet]. Available from: https://www.nidcr.nih.gov/research/data-statistics/facial-pain/prevalence
Shueb S.S., Nixdorf D.R., John M.T., Alonso B.F., Durham J. ScienceDirect What is the impact of acute and chronic orofacial pain on quality of life ? J Dent [Internet]. 2015; 43 (10): 1203-10. Available from: http://dx.doi.org/10.1016/j.jdent.2015.06.001
Lei J., Yap A.U., Zhang M., Fu K-Y. Temporomandibular disorder subtypes, emotional distress, impaired sleep, and oral health-related quality of life in Asian patients. Community Dent Oral Epidemiol [Internet]. 2021; 49 (6): 543-9. Available from: http://dx.doi.org/10.1111/cdoe.12643
Benoliel R., Committeee TOPC. International Classification of Orofacial Pain, 1st edition (ICOP). Cephalalgia. 2020; 40 (2): 129-221.
Schiffman E., Ohrbach R., Truelove E., Look J., Anderson G., Goulet J-P, et al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: Recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†. J Oral Facial Pain Headache [Internet]. 2014; 28 (1): 6-27. Available from: http://www.quintpub.com/journals/ofph/abstract.php?iss2_id=1172&article_id=13908&article=2&title=Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: Recommendations of the International RDC/TMD Consortium N
Slade G.D., Fillingim R.B., Sanders A.E., Bair E., Greenspan J.D., Ohrbach R., et al. Summary of Findings From the OPPERA Prospective Cohort Study of Incidence of First-Onset Temporomandibular Disorder: Implications and Future Directions. J Pain [Internet]. 2016; 14 (12): T116-24. Available from: http://dx.doi.org/10.1016/j.jpain.2013.09.010
Maixner W., Diatchenko L., Dubner R., Fillingim R.B., Greenspan J.D., Knott C., et al. Orofacial pain prospective evaluation and risk assessment study - The OPPERA study. J Pain. 2011; 12 (11 SUPPL.): 1-13.
Anderson G.C., John M.T., Ohrbach R., Nixdorf D.R., Schiffman EL, Truelove ES, et al. Influence of headache frequency on clinical signs and symptoms of TMD in subjects with temple headache and TMD pain. Pain. 2011; 152 (4): 765-71.
Reid K.I., Greene CS. Diagnosis and treatment of temporomandibular disorders: An ethical analysis of current practices. J Oral Rehabil. 2013; 40 (7): 546-61.
Zakrzewska J.M. Multi-dimensionality of chronic pain of the oral cavity and face. J Headache Pain [Internet]. 2013; 14: 37. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3642003&tool=pmcentrez&rendertype=abstract
Porporatti A.L., Costa Y.M., Bonjardim L.R., Stuginski-Barbosa J., Rodrigues Conti P.C., Martori A.H. The coexistence of paroxysmal hemicrania and temporomandibular disorder: Importance of multidisciplinary approach. Indian J Dent Res. 2014; 25 (1): 119-21.
Fricton J. Myofascial Pain Mechanisms to Management. Oral Maxillofac Surg Clin NA [Internet]. 2016; 28 (3): 289-311. Available from: http://dx.doi.org/10.1016/j.coms.2016.03.010
List T., Axelsson S. Management of TMD: Evidence from systematic reviews and meta-analyses. J Oral Rehabil. 2010; 37 (6): 430-51.
Slade G.D., Bair E., Greenspan J.D., Dubner R., Fillingim R.B., Diatchenko L., et al. Signs and symptoms of first-onset TMD and sociodemographic predictors of its development: The OPPERA prospective cohort study. J Pain [Internet]. 2013;14 (12 SUPPL.): T20-T32.e3. Available from: http://dx.doi.org/10.1016/j.jpain.2013.07.014